Literature DB >> 28574228

aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.

Yawei Qian1, Wei Yao1, Tao Yang1, Yan Yang2, Yan Liu1, Qi Shen1, Jian Zhang1, Weipeng Qi1, Jianming Wang1.   

Abstract

Cholangiocarcinoma (CCA) is a highly malignant bile duct cancer that tends to invade and metastasize early. The epithelial-mesenchymal transition (EMT) has been implicated in cancer cell invasion and metastasis, as well as in cancer cell evasion of host immunity. In this study, we investigated the interaction between atypical protein kinase C-iota (aPKC-ι) and Snail in the regulation of EMT and its relationship to CCA immunosuppression. Our results demonstrated that aPKC-ι, Snail, and infiltrated immunosuppressive cells were significantly up-regulated in CCA tumor tissues and linked to poor prognosis. aPKC-ι induced EMT and immunosuppression by regulating Snail in vitro and in vivo, although aPKC-ι did not directly interact with Snail in coimmunoprecipitation experiments. To further clarify the molecular interaction between aPKC-ι and Snail in relation to EMT, quantitative iTRAQ-based phosphoproteomic analysis and liquid chromatography-tandem mass spectrometry were conducted to identify the substrates of aPKC-ι-dependent phosphorylation. Combined with coimmunoprecipitation, we showed that specificity protein 1 (Sp1) was directly phosphorylated by aPKC-ι on Ser59 (P-Sp1). Both Sp1 and P-Sp1 were up-regulated in CCA tumor tissues and associated with clinicopathological features and poor prognosis in CCA patients. Moreover, using chromatin immunoprecipitation assays, we found that P-Sp1 regulated Snail expression by increasing Sp1 binding to the Snail promoter. P-Sp1 also regulated aPKC-ι/Snail-induced EMT-like changes and immunosuppression in CCA cells. Our findings further indicated that CCA cells with EMT-like features appear to generate immunosuppressive natural T regulatory-like cluster of differentiation 4-positive (CD4+ )CD25- cells rather than to increase CD4+ CD25+ natural T regulatory cells, in part by mediating T regulatory-inducible cytokines such as transforming growth factor β1 and interleukin 2.
CONCLUSION: These results demonstrate that aPKC-ι promotes EMT and induces immunosuppression through the aPKC-ι/P-Sp1/Snail signaling pathway and may be a potential therapeutic target for CCA. (Hepatology 2017;66:1165-1182).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28574228     DOI: 10.1002/hep.29296

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.

Authors:  Jianhua Yu; Lawrence Shi; Xinggui Shen; Yunfeng Zhao
Journal:  Biochem Pharmacol       Date:  2019-05-11       Impact factor: 5.858

2.  SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.

Authors:  Meng Xu; Jingxiao Wang; Zhong Xu; Rong Li; Pan Wang; Runze Shang; Antonio Cigliano; Silvia Ribback; Antonio Solinas; Giovanni Mario Pes; Katja Evert; Haichuan Wang; Xinhua Song; Shu Zhang; Li Che; Rosa Maria Pascale; Diego Francesco Calvisi; Qingguang Liu; Xin Chen
Journal:  Cancer Res       Date:  2019-08-05       Impact factor: 12.701

3.  MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.

Authors:  Mingjie Xu; Jiangfeng Li; Xiao Wang; Shuai Meng; Jiaying Shen; Song Wang; Xin Xu; Bo Xie; Ben Liu; Liping Xie
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

4.  Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.

Authors:  Yan Wang; Yingjian Liang; Guangchao Yang; Yaliang Lan; Jihua Han; Jiabei Wang; Dalong Yin; Ruipeng Song; Tongsen Zheng; Shugeng Zhang; Shangha Pan; Xirui Liu; Mingxi Zhu; Yao Liu; Yifeng Cui; Fanzheng Meng; Bo Zhang; Shuhang Liang; Hongrui Guo; Yufeng Liu; Md Khaled Hassan; Lianxin Liu
Journal:  J Exp Clin Cancer Res       Date:  2018-12-04

5.  Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP.

Authors:  Hui Wang; Kai Li; Yu Mei; Xuemei Huang; Zhenglin Li; Qingzhu Yang; Huanjie Yang
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-26       Impact factor: 8.886

Review 6.  Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

Authors:  Hong-Tao Chen; Hao Liu; Min-Jie Mao; Yuan Tan; Xiang-Qiong Mo; Xiao-Jun Meng; Meng-Ting Cao; Chu-Yu Zhong; Yan Liu; Hong Shan; Guan-Min Jiang
Journal:  Mol Cancer       Date:  2019-05-24       Impact factor: 27.401

7.  Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway.

Authors:  Li Tian; Zhengdong Deng; Lei Xu; Tao Yang; Wei Yao; Lei Ji; Yun Lu; Jian Zhang; Yan Liu; Jianming Wang
Journal:  Cell Death Dis       Date:  2018-11-02       Impact factor: 8.469

8.  HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9.

Authors:  Dong-Qin Chen; Chen Yu; Xue-Feng Zhang; Zhong-Fang Liu; Rui Wang; Min Jiang; Hao Chen; Feng Yan; Min Tao; Long-Bang Chen; Hong Zhu; Ji-Feng Feng
Journal:  Ther Adv Med Oncol       Date:  2018-07-11       Impact factor: 8.168

9.  Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p.

Authors:  Hui Jiang; Guanqun Huang; Nianzhang Zhao; Ting Zhang; Mengni Jiang; Yueming He; Xinke Zhou; Xianhan Jiang
Journal:  J Exp Clin Cancer Res       Date:  2018-07-25

10.  SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis.

Authors:  Yue Gao; Kai Gan; Kuangzheng Liu; Bin Xu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-01-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.